Relaxo Footwears (RELAXO) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
13 Aug, 2026Executive summary
Achieved revenue of ₹705.05 Cr in Q1FY27, up from ₹654.49 Cr YoY, with PAT rising to ₹54.94 Cr and EBITDA margin improving to 15.35%.
Annual FY26 revenue was ₹2,702.16 Cr, with PAT at ₹179.27 Cr and EBITDA margin at 13.84%.
Maintained strong manufacturing capacity and diversified product portfolio, with ongoing modernization and recalibration of production.
Total comprehensive income for the quarter reached ₹55.39 Cr, up from ₹49.20 Cr YoY.
Financial highlights
Q1FY27 revenue grew 7.7% YoY to ₹705.05 Cr; PAT margin improved to 7.79%.
EBITDA for Q1FY27 was ₹108.23 Cr, up 8.8% YoY; EBITDA margin at 15.35%.
FY26 revenue at ₹2,702.16 Cr, PAT at ₹179.27 Cr, and cash PAT at ₹333 Cr.
Earnings per share (basic and diluted) for Q1FY27 were ₹2.21, up from ₹1.96 YoY.
Profit before tax for the quarter was ₹75.08 Cr, compared to ₹65.91 Cr YoY.
Outlook and guidance
Indian footwear market expected to grow at 9.7% CAGR through 2034, with organized sector expanding at 13% CAGR.
Company upgrading manufacturing facilities to support future growth and optimize infrastructure.
The Board of Directors reviewed and approved the results on August 13, 2026, with no modifications from the statutory auditors.
Latest events from Relaxo Footwears
- FY26 saw lower revenue but higher profit and margins, with a strong dividend and digital focus.RELAXO
Q4 25/26 - Q3FY26 saw stable revenue but lower profit, while FY25 ended with strong cash and growth outlook.RELAXO
Q3 25/26 - Q2 FY26 revenue fell 7.5% YoY, but margins and cash flow remained resilient.RELAXO
Q2 25/26 - Q1FY26 profit and EPS rose despite lower revenue, with margin gains and strong cash flow.RELAXO
Q1 25/26 - Revenue and profit fell, but margins held steady and Q3 demand recovery is anticipated.RELAXO
Q2 24/25 - Q1FY25 revenue increased 1.3% year-over-year, but net profit and margins declined.RELAXO
Q1 24/25 - FY25 saw lower revenue and profit, but margin gains, premiumization, and a stable dividend are expected.RELAXO
Q4 24/25 - Q3 FY25 revenue and profit fell, but credit ratings and industry outlook remain strong.RELAXO
Q3 24/25